LOS ANGELES, CALIFORNIA — January 31, 2012 — Catasys, Inc. (CATS)
announced today that it has entered into a multi-year agreement with Coventry Health Care of Oklahoma, Inc., a subsidiary of Coventry Health Care Inc., to provide the OnTrak™ integrated substance dependence solution to its commercial members. This represents a further expansion of the relationship with Coventry Health Care, one of the country’s largest health insurance companies, into a third region. Implementation is under way and the program is expected to launch in the second quarter of 2012.
Eligible commercial members of Coventry Health Care of Oklahoma affected by substance dependence will be covered under the Catasys program, which includes medical and psychosocial interventions, as well as care coaching over a 52 week period. Coventry Health Care of Oklahoma will pay Catasys monthly payments covering enrolled members’ OnTrak treatment program. Catasys will enroll eligible members directly and also in conjunction with health plan programs and staff.
“We are pleased to again be expanding our relationship with Coventry Health Care in Oklahoma,” said Rick Anderson, Catasys President and COO. “This represents our first contract of the new year and continues to add to the base of lives covered by our OnTrak program. We look forward to continuing this momentum early this year.”
About Catasys®
Catasys, Inc. provides specialized health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Catasys substance dependence program was designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence. For further information, please visit www.catasyshealth.com.
Forward-Looking Statements
Except
for statements of historical fact, the matters discussed in this press
release are forward looking and made pursuant to the Safe Harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements reflect numerous assumptions and
involve a variety of risks and uncertainties, many of which are beyond
the company's control that may cause actual results to differ materially
from stated expectations. These risk factors include, among others,
changes in regulations or issuance of new regulations or
interpretations, limited operating history and lack of outcomes and
statistically significant formal research studies, difficulty enrolling
members in our programs, the risk that treatment programs might not be
effective, difficulty in developing, exploiting and protecting
proprietary technologies, intense competition and substantial regulation
in the health care industry; and additional risks factors as discussed
in the reports filed by the company with the Securities and Exchange
Commission, which are available on its website at http://www.sec.gov
Contact:
Terri MacInnis, Director of Investor Relations
terri@bibimac.com
Phone: 818-379-8500
Bibicoff + MacInnis, Inc.
|
